Advisors Preferred’s Novo Nordisk NVO Stock Holding History

Advisors Preferred’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,440	Closed	-$85.2K	–	284
2025 Q3	$85.2K	Buy	+1,440	New	+$84.3K	0.01%	211
2025 Q1	–	Sell	-232	Closed	-$20.3K	–	309
2024 Q4	$20.3K	Buy	+232	New	+$25.1K	﹤0.01%	181
2024 Q3	–	Sell	-603	Closed	-$87.7K	–	232
2024 Q2	$87.7K	Buy	+603	New	+$79.9K	0.02%	143
2024 Q1	–	Sell	-67	Closed	-$6.84K	–	252
2023 Q4	$6.84K	Sell	67 -39	-37%	-$3.86K	﹤0.01%	221
2023 Q3	$9.73K	Sell	106 -48	-31%	-$4.23K	﹤0.01%	180
2023 Q2	$12.3K	Hold	154	–	–	﹤0.01%	150
2023 Q1	$12.3K	Sell	154 -96	-38%	-$6.81K	﹤0.01%	166
2022 Q4	$17.1K	Buy	+250	New	+$14.7K	0.01%	146
2020 Q1	–	Sell	-3,594	Closed	-$104K	–	221
2019 Q4	$104K	Buy	3,594 +3,000	+505%	+$83.1K	0.03%	150
2019 Q3	$15K	Sell	594 -396	-40%	-$10K	﹤0.01%	190
2019 Q2	$26K	Buy	+990	New	+$24.5K	0.01%	178
2016 Q2	–	Sell	-402	Closed	-$11K	–	278
2016 Q1	$11K	Sell	402 -48	-11%	-$1.29K	0.01%	148
2015 Q4	$13K	Sell	450 -194	-30%	-$5.37K	0.01%	163
2015 Q3	$17K	Buy	+644	New	+$18.2K	0.02%	110
2014 Q2	–	Sell	-1,246	Closed	-$28.4K	–	415
2014 Q1	$28.4K	Buy	1,246 +326	+35%	+$6.95K	0.01%	302
2013 Q4	$16K	Buy	+920	New	+$16K	0.01%	310

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Advisors Preferred's NVO Position: Q4 2025 in Review

Advisors Preferred sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 1,440 shares — an estimated $85.2K sold.

Advisors Preferred first reported a position in NVO in Q4 2013 and held it in 16 quarters. The position peaked at $104K in Q4 2019. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

Advisors Preferred reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
Advisors Preferred sold 1,440 Novo Nordisk shares in Q4 2025, an estimated $85.2K.
Advisors Preferred first reported a position in Novo Nordisk in Q4 2013 and held it in 16 quarters.
Advisors Preferred's Novo Nordisk position peaked at $104K in Q4 2019.
1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Advisors Preferred's 13F filing for Q4 2025, filed 2 Feb 2026.